Protalix BioTherapeutics Inc (PLX)
1.135
-0.02
(-2.16%)
USD |
NYAM |
May 15, 14:44
Protalix BioTherapeutics Revenue (Annual): 65.49M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 65.49M |
| December 31, 2022 | 47.64M |
| December 31, 2021 | 38.35M |
| December 31, 2020 | 62.90M |
| December 31, 2019 | 54.69M |
| December 31, 2018 | 34.24M |
| December 31, 2017 | 21.08M |
| December 31, 2016 | 9.199M |
| December 31, 2015 | 4.364M |
| December 31, 2014 | 3.523M |
| December 31, 2013 | |
| December 31, 2012 | 34.42M |
| December 31, 2011 | 2.968M |
| Date | Value |
|---|---|
| December 31, 2010 | 11.24M |
| December 31, 2009 | 0.388M |
| December 31, 2008 | |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | 0.15M |
| December 31, 2004 | 0.43M |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | |
| December 31, 1999 | 3.555M |
| December 31, 1998 | 8.036M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
38.35M
Minimum
2021
65.49M
Maximum
2023
53.81M
Average
54.69M
Median
2019
Revenue (Annual) Benchmarks
| Agenus Inc | 156.31M |
| InfuSystems Holdings Inc | 125.78M |
| AIM ImmunoTech Inc | 0.202M |
| Perspective Therapeutics Inc | -- |
| Armata Pharmaceuticals Inc | -- |